SEC Form 4 · accession 0001193125-26-260007
LEMAITRE VASCULAR INC · LMAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dorian Paul LeBlanc
Officer — Chief Financial Officer
Period of report
Jun 4, 2026
Accepted (ET)
Jun 5, 2026 · 5:33 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001158895
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Equivalent RightsF1 | — | Jun 4, 2026 | A | 2 | A | — | — | Common Stock | 2 | 14 | D |
| Dividend Equivalent RightsF2 | — | Jun 4, 2026 | A | 3 | A | — | — | Common Stock | 3 | 6 | D |
Explanation of responses
- F1These dividend equivalent rights accrued on a restricted stock unit award granted on 3/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
- F2These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.